F. tularensis is a highly infectious Gram-negative bacterial pathogen that causes tularemia, a re-emerging zoonosis of public health concern. Here we identify respiratory complex I as a selective vulnerability in Francisella and define the mechanism of action of a pyrazole compound, tolfenpyrad, with species-specific antibacterial activity. Using F. novicida as a surrogate model, we demonstrated that tolfenpyrad selectively inhibits growth with no measurable effect on E. coli or P. aeruginosa. Tolfenpyrad rapidly suppressed oxygen consumption, depleted ATP, collapsed proton motive force, and induced reactive oxygen species, indicating disruption of bacterial metabolism. Biochemical assays demonstrated selective inhibition of NADH-dependent respiration and membrane-associated NADH oxidation, whereas succinate-driven respiration was unaffected. Moreover, the alternative NADH dehydrogenase (ndh) was not required for tolfenpyrad activity. Structural docking identified a potential tolfenpyrad-binding pocket within the membrane subunit NuoM. These findings reveal species-specific inhibition of Francisella complex I and establish respiratory metabolism as a promising antimicrobial target in these bacteria.
Khalid, N., Van Horn, C. M., Li, D., Ostrov, D., Eshraghi, A.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0